Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
ACT-Accelerator We co-convene the diagnostics pillar of this global collaboration to ensure access to COVID-19 tests for everyone, everywhere.
G20 in India We are highlighting the importance of diagnostics in ensuring that the G20 health priorities are achieved.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
Diagnostics & IP Find out how intellectual property rights are protected in the diagnostics industry.
Press release FIND welcomes adoption of historic World Health Assembly Resolution on diagnostics as the organization enters its 20th anniversary year
DxConnect Tools and resources provided under the DxConnect umbrella contain information managed and collated – but not owned – by FIND, as a service to the diagnostics community.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
Diagnostics Commission The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
To G20 leaders To uphold diagnostics and equitable access to testing within their commitments to support sustainable recovery from COVID-19.
Following a Women Political Leaders' Summit, to global leaders On the urgent need to scale up testing and ensure immediate equitable access to diagnostics.
To WHO Member States To commit to gender equality and human rights in the new international instrument to maintain a firm focus on equitable prevention, preparedness and response that leaves no one behind.
